/biz/ - Business & Finance

[Anonymous No.316379]

Post your business role models husbandos

Peter C Farrell, PhD, ScD, AM, Non-Executive Chairman
Experience

Commercial

Founder, Chairman and Chief Executive of ResMed Inc, an ASX and New York Stock Exchange (NYSE) listed sleep and respiration medical equipment company.

Director of Pharmaxis Limited (ASX: PXS).

Professional

Pater Farrel has 30 years of executive and consulting experience in the medical device industry.

Education and research:

Dr Farrell is a Fellow of several professional bodies, including the Australian Institutes of Management and Company Directors.

Dr Farrell is also a Visiting Professor at the University of New South Wales Graduate School for Biomedical Engineering, of which he was founding Director in 1978.

He holds Bachelors and Masters degrees in chemical engineering from the University of Sydney and the Massachusetts Institute of Technology (MIT) respectively, a PhD in bioengineering from the University of Washington in Seattle, and a ScD from the University of New South Wales for research related to dialysis and renal medicine.

[Anonymous No.316386]

John W Holaday, PhD, Managing Director, CEO and CSO
Commercial experience:

Dr. John Holaday is the Managing Director, CEO, Chief Scientific Officer and founding Director of QRxPharma (QRX, ASX).

Co-founder of EntreMed, Inc. (ENMD, NASDAQ) in 1992, Medicis Pharmaceutical Corp. (MRX, NYSE) in 1988. He also founded MaxCyte, Inc.

He is a member of the Board of Directors of Neuren (ASX), Pixspan, Plasmonix, CytImmune Sciences and Accelovance.

He has raised over $500MM in private and public rounds of financing for these companies that have a collective market capitalization in excess of $2 billion.

Dr. Holaday holds over 65 patents

Military:

Dr. Holaday served as a Captain in the US Army, and was at the Walter Reed Army Institute of Research as an officer and civilian for 21 years.

Education and research:

Dr. Holaday obtained his BS (1966) and MS (1968) from the University of Alabama (UofA), and his PhD from the University of California, San Francisco in 1976.

He was Professor of Anesthesiology and Critical Care Medicine at the Johns Hopkins University School of Medicine (until 1996) and is Professor of Psychiatry at the Uniformed Services University of the Health Sciences.

He is former Chair of the BioAlliance of the Tech Council of Maryland. Dr. Holaday serves on the Leadership Board for the College of Arts and Sciences, UofA, formerly with the Leadership Board of the University of Maryland Biotechnology Institute.

Published over 230 scientific articles, book chapters and four books.

[Anonymous No.316418]

Scientific Advisory Board

Solomon H Snyder, MD,
● Chairman, Scientific Advisory Board

Solomon H Snyder, MD, Chairman
Chairman of QRxPharma’s Scientific Advisory Board.

Education and research:

In 1973, Dr Snyder identified the opioid receptor. For this he was awarded the Albert Lasker Award for Basic Medical Research in 1978.

Dr Snyder currently serves as the Distinguished Service Professor of Neuroscience, Pharmacology and Psychiatry at The Johns Hopkins University School of Medicine.

He is also Associate Editor of the Proceedings of the National Academy of Sciences of the US,

He is the author of more than 1,000 journal articles and several books.

He is listed by the Institute for Scientific Information as one of the world’s ten most-often cited biologists.

Dr Snyder also co-founded Nova Pharmaceuticals and Guilford Pharmaceuticals, where he served on the Boards of Directors.

Dr Snyder received his medical degree from Georgetown University in 1958, and graduated from Georgetown Medical School in 1962. Post-doctorally, he studied at the National Institute of Health and completed his residency in psychiatry at The Johns Hopkins Hospital. In 1966, Dr Snyder joined the faculty of The Johns Hopkins University School of Medicine where he formed the Department of Neuroscience in 1980.